Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Mathai

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
International Review of Psychiatry (Abingdon, England)|February 21, 2025
Learning how to make use of dissociative therapiesDavid S Mathai
Frontiers in Psychology|April 11, 2022
Toward Synergies of Ketamine and PsychotherapyDavid S Mathai, Victoria Mora, Albert Garcia-Romeu
Journal of Affective Disorders|May 29, 2024
At-home, telehealth-supported ketamine treatment for depression: Findings from longitudinal, machine learning and symptom network analysis of real-world dataDavid S Mathai, Thomas D Hull, Leonardo Vando, et al.
Scientific Reports|November 14, 2024
Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionalsErin Wang, David S Mathai, Natalie Gukasyan, et al.
Journal of Affective Disorders|February 15, 2020
The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic reviewDavid S Mathai, Matthew J Meyer, Eric A Storch, et al.
Psychopharmacology|February 2, 2023
Reconsidering "dissociation" as a predictor of antidepressant efficacy for esketamineDavid S Mathai, Sandeep M Nayak, David B Yaden, et al.
Journal of Psychopharmacology (Oxford, England)|October 18, 2019
Recovery from impaired working memory performance during chronic Δ-9-tetrahydrocannabinol administration to adolescent rhesus monkeysChristopher D Verrico, David S Mathai, Hong Gu, et al.
The American Journal on Addictions|October 18, 2016
"Just one bad high:" considering synthetic cannabinoid outcome expectancies in adolescentsDavid S Mathai, Christopher D Verrico, Daryl Shorter, et al.
Expert Review of Neurotherapeutics|July 21, 2020
Deep transcranial magnetic stimulation for obsessive compulsive disorderAlexis G McCathern, David S Mathai, Raymond Y Cho, et al.
Journal of Affective Disorders|June 26, 2022
Mapping consent practices for outpatient psychiatric use of ketamineDavid S Mathai, Scott M Lee, Victoria Mora, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
International Review of Psychiatry (Abingdon, England)|February 21, 2025
Learning how to make use of dissociative therapiesDavid S Mathai
Frontiers in Psychology|April 11, 2022
Toward Synergies of Ketamine and PsychotherapyDavid S Mathai, Victoria Mora, Albert Garcia-Romeu
Journal of Affective Disorders|May 29, 2024
At-home, telehealth-supported ketamine treatment for depression: Findings from longitudinal, machine learning and symptom network analysis of real-world dataDavid S Mathai, Thomas D Hull, Leonardo Vando, et al.
Scientific Reports|November 14, 2024
Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionalsErin Wang, David S Mathai, Natalie Gukasyan, et al.
Journal of Affective Disorders|February 15, 2020
The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic reviewDavid S Mathai, Matthew J Meyer, Eric A Storch, et al.
Psychopharmacology|February 2, 2023
Reconsidering "dissociation" as a predictor of antidepressant efficacy for esketamineDavid S Mathai, Sandeep M Nayak, David B Yaden, et al.
Journal of Psychopharmacology (Oxford, England)|October 18, 2019
Recovery from impaired working memory performance during chronic Δ-9-tetrahydrocannabinol administration to adolescent rhesus monkeysChristopher D Verrico, David S Mathai, Hong Gu, et al.
The American Journal on Addictions|October 18, 2016
"Just one bad high:" considering synthetic cannabinoid outcome expectancies in adolescentsDavid S Mathai, Christopher D Verrico, Daryl Shorter, et al.
Expert Review of Neurotherapeutics|July 21, 2020
Deep transcranial magnetic stimulation for obsessive compulsive disorderAlexis G McCathern, David S Mathai, Raymond Y Cho, et al.
Journal of Affective Disorders|June 26, 2022
Mapping consent practices for outpatient psychiatric use of ketamineDavid S Mathai, Scott M Lee, Victoria Mora, et al.
Pageof 3